StockData
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc. (APVO) stock

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.45−0.02 (-3.25%)

Close on Nov 18, 2026Market cap $803.68KP/E –Yield –

Aptevo Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Aptevo Therapeutics's price to sales ratio was 438.7× on Apr 30, 2020.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Apr 30, 2020438.7×–

More Aptevo Therapeutics figures

See a number that looks wrong?